These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 3471320)
1. Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line. Hoosein NM; Brattain DE; McKnight MK; Levine AE; Brattain MG Cancer Res; 1987 Jun; 47(11):2950-4. PubMed ID: 3471320 [TBL] [Abstract][Full Text] [Related]
2. Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-beta binding to a human colon carcinoma cell line. Levine AE; Black B; Brattain MG J Cell Physiol; 1989 Mar; 138(3):459-66. PubMed ID: 2925796 [TBL] [Abstract][Full Text] [Related]
3. Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line. Mulder KM; Ramey MK; Hoosein NM; Levine AE; Hinshaw XH; Brattain DE; Brattain MG Cancer Res; 1988 Dec; 48(24 Pt 1):7120-5. PubMed ID: 3191488 [TBL] [Abstract][Full Text] [Related]
4. Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor-beta. Chakrabarty S; Tobon A; Varani J; Brattain MG Cancer Res; 1988 Jul; 48(14):4059-64. PubMed ID: 3289738 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells. Zipfel PA; Ziober BL; Morris SL; Mulder KM Cell Growth Differ; 1993 Aug; 4(8):637-45. PubMed ID: 8398905 [TBL] [Abstract][Full Text] [Related]
6. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta. Chakrabarty S; Jan Y; Brattain MG; Tobon A; Varani J Cancer Res; 1989 Apr; 49(8):2112-7. PubMed ID: 2539253 [TBL] [Abstract][Full Text] [Related]
7. Effects of N,N-dimethylformamide and retinoic acid on transforming growth factor-beta induced mitogenesis in AKR-2B mouse embryo fibroblasts. Levine AE; Crandall CA Cancer Res; 1987 Aug; 47(16):4278-82. PubMed ID: 3496961 [TBL] [Abstract][Full Text] [Related]
8. N,N-dimethylformamide-induced synthesis of an anti-fibronectin reactive protein in cultured human colon carcinoma cells. Marks ME; Ziober BL; Brattain MG Cancer Res; 1986 Oct; 46(10):5248-58. PubMed ID: 3756877 [TBL] [Abstract][Full Text] [Related]
9. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines. Hébert CD; Birnbaum LS Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation. Hafez MM; Infante D; Winawer S; Friedman E Cell Growth Differ; 1990 Dec; 1(12):617-26. PubMed ID: 2288877 [TBL] [Abstract][Full Text] [Related]
11. Purification and biological properties of type beta transforming growth factor from mouse transformed cells. Fernandez-Pol JA; Klos DJ; Grant GA Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522 [TBL] [Abstract][Full Text] [Related]
12. Clonal heterogeneity of the sensitivity of human colon carcinoma cell lines to TGE beta isoforms. Zhou GH; Sechrist GL; Brattain MG; Mulder KM J Cell Physiol; 1995 Dec; 165(3):512-20. PubMed ID: 7593230 [TBL] [Abstract][Full Text] [Related]
13. Production of transforming growth factors by human colon cancer lines. Coffey RJ; Shipley GD; Moses HL Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610 [TBL] [Abstract][Full Text] [Related]
14. Up-regulation of c-myc in a transformed cell line approaching stationary phase growth in culture. Mulder KM; Levine AE; Hinshaw XH Cancer Res; 1989 May; 49(9):2320-6. PubMed ID: 2706619 [TBL] [Abstract][Full Text] [Related]
15. Identification of endogenous inhibitory growth factors from a human colon carcinoma cell line. Levine AE; McRae LJ; Hamilton DA; Brattain DE; Yeoman LC; Brattain MG Cancer Res; 1985 May; 45(5):2248-54. PubMed ID: 3857117 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta isoform-specific differences in interactions with type I and II transforming growth factor beta receptors. Zhou GH; Sechrist GL; Periyasamy S; Brattain MG; Mulder KM Cancer Res; 1995 May; 55(10):2056-62. PubMed ID: 7743502 [TBL] [Abstract][Full Text] [Related]
17. Alterations of the biological characteristics of a colon carcinoma cell line by colon-derived substrata material. Boyd D; Florent G; Chakrabarty S; Brattain D; Brattain MG Cancer Res; 1988 May; 48(10):2825-31. PubMed ID: 3162826 [TBL] [Abstract][Full Text] [Related]
18. Role of transforming growth factor beta 1 in induction of colon carcinoma differentiation by hexamethylene bisacetamide. Schroy P; Rifkin J; Coffey RJ; Winawer S; Friedman E Cancer Res; 1990 Jan; 50(2):261-5. PubMed ID: 2295065 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of transforming growth factor beta, N,N-dimethylformamide, and retinoic acid on transformed and nontransformed fibroblasts. Hoosein NM; Brattain DE; McKnight MK; Brattain MG Exp Cell Res; 1988 Mar; 175(1):125-35. PubMed ID: 3162213 [TBL] [Abstract][Full Text] [Related]
20. The differential effects of N,N-dimethylformamide and transforming growth factor-beta 1 on a human ovarian cancer cell line (HOC-7). Grunt TW; Somay C; Ellinger A; Pavelka M; Dittrich E; Dittrich C J Cell Physiol; 1992 Apr; 151(1):13-22. PubMed ID: 1560038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]